Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome and Unmasking of Tuberculosis by Antiretroviral Therapy
Authors:
- Graeme MeintjesGMGraeme Meintjes
- Helena RabieHRHelena Rabie
- Robert J. WilkinsonRWRobert J. Wilkinson
- Mark F. CottonMCMark F. Cotton
- 1 December 2009
- journal article
- review article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 30 (4) , 797-810
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- TuberculosisThe Lancet, 2007
- Tuberculosis after Initiation of Antiretroviral Therapy in Low-Income and High-Income CountriesClinical Infectious Diseases, 2007
- Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West AfricaAIDS, 2007
- Mortality in the Highly Active Antiretroviral Therapy EraJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis controlAIDS, 2006
- Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatmentThe Lancet, 2006
- Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohortAIDS, 2005
- Tuberculosis in HIV‐infected persons in the context of wide availability of highly active antiretroviral therapyEuropean Respiratory Journal, 2004
- Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort studyThe Lancet, 2002
- Immune restoration and CD4+ T-cell function with antiretroviral therapiesAIDS, 2001